Cannabis Research

Cannabis Research

Rowan University Institute for Cannabis Research, Policy, & Workforce Development

Center for Cannabinoid Science & Therapeutics

Contact Dr. Gustavo Moura Letts at moura-letts@rowan.edu for more information.
 
There has been a dramatic increase in the use of cannabis (marijuana)-derived products in the United States. The legality of the sale of cannabis extracts enriched in cannabinoids that do not have the psychoactive substance (−)-trans-Δ⁹-tetrahydrocannabinol (THC) is complex and evolving. Despite the unclear regulatory status of these compounds, they can be found in a vast number of commercial products that are purported to have a wide variety of health-promoting effects. In addition, there is a nationwide trend in marijuana legalization which includes products containing THC. 
 
The legalization of marijuana and related products has not been accompanied by concomitant research into the health benefits and risks of these products. Thus, the push towards legalization may be accompanied by significant risks to public health. 
 
The scientific core of the Institute is designed to systematically investigate the active compounds in cannabis extracts, their actions, and effects on long-term health and well-being.